Evidence map›Paper›PMID 36194270›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2023

Mitigating bias in deep learning for diagnosis of coronary artery disease from myocardial perfusion SPECT images.

Robert J H Miller, Ananya Singh, Yuka Otaki, Balaji K Tamarappoo, Paul Kavanagh, Tejas Parekh, Lien-Hsin Hu, Heidi Gransar, Tali Sharir, Andrew J Einstein and 12 more

Abstract readComment
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Deep learning-based obstructive coronary artery disease prediction from myocardial perfusion SPECT.European journal of nuclear medicine and molecular imaging · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Artificial Intelligence in Nuclear Cardiology.Journal of clinical medicine · 2025
    Review
  9. Article
  10. Article
  11. AI in SPECT Imaging: Opportunities and Challenges.Seminars in nuclear medicine · 2025
    Review
  12. Artificial Intelligence-Enhanced Perfusion Scoring Improves the Diagnostic Accuracy of Myocardial Perfusion Imaging.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Robert J H Miller *Departments of Medicine, Division of Artificial Intelligence, Imaging and Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Ste. Metro 203, Los Angeles, CA, 90048, USA.
Ananya Singh *Departments of Medicine, Division of Artificial Intelligence, Imaging and Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Ste. Metro 203, Los Angeles, CA, 90048, USA.
Yuka OtakiDepartments of Medicine, Division of Artificial Intelligence, Imaging and Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Ste. Metro 203, Los Angeles, CA, 90048, USA.
Balaji K TamarappooDepartments of Medicine, Division of Artificial Intelligence, Imaging and Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Ste. Metro 203, Los Angeles, CA, 90048, USA.
Paul KavanaghDepartments of Medicine, Division of Artificial Intelligence, Imaging and Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Ste. Metro 203, Los Angeles, CA, 90048, USA.
Tejas ParekhDepartments of Medicine, Division of Artificial Intelligence, Imaging and Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Ste. Metro 203, Los Angeles, CA, 90048, USA.
Lien-Hsin HuDepartments of Medicine, Division of Artificial Intelligence, Imaging and Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Ste. Metro 203, Los Angeles, CA, 90048, USA.
Heidi GransarDepartments of Medicine, Division of Artificial Intelligence, Imaging and Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Ste. Metro 203, Los Angeles, CA, 90048, USA.
Tali SharirDepartment of Nuclear Cardiology, Assuta Medical Centers, Tel Aviv, Israel and Ben Gurion University of the Negev, Beer Sheba, Israel.
Andrew J EinsteinDepartment of Medicine, and Department of Radiology, Division of Cardiology, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, NY, USA.
Mathews B FishOregon Heart and Vascular Institute, Sacred Heart Medical Center, Springfield, OR, USA.
Terrence D RuddyDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, ON, Canada.
Philipp A KaufmannDepartment of Nuclear Medicine, Cardiac Imaging, University Hospital Zurich, Zurich, Switzerland.
Albert J SinusasSection of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.
Edward J MillerSection of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.
Timothy M BatemanCardiovascular Imaging Technologies LLC, Kansas City, MO, USA.
Sharmila DorbalaDepartment of Radiology, Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital, Boston, MA, USA.
Marcelo F Di CarliDepartment of Radiology, Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital, Boston, MA, USA.
Joanna X LiangDepartments of Medicine, Division of Artificial Intelligence, Imaging and Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Ste. Metro 203, Los Angeles, CA, 90048, USA.
Damini DeyDepartments of Medicine, Division of Artificial Intelligence, Imaging and Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Ste. Metro 203, Los Angeles, CA, 90048, USA.
Daniel S BermanDepartments of Medicine, Division of Artificial Intelligence, Imaging and Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Ste. Metro 203, Los Angeles, CA, 90048, USA.
Piotr J SlomkaDepartments of Medicine, Division of Artificial Intelligence, Imaging and Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Ste. Metro 203, Los Angeles, CA, 90048, USA. Piotr.Slomka@cshs.org.

Funding

Quantitative Prediction of Disease and Outcomes from Next Generation SPECT and CTR01HL089765 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI SLOMKA, PIOTR J · 2007 to 2021
$6.1M
Patient-specific Outcome Prediction from Cardiovascular Multimodality Imaging by Artificial IntelligenceR35HL161195 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI Piotr J Slomka · 2022 to 2026
$5.0M
NHLBI NIH HHS R01 HL089765NHLBI NIH HHS R01HL089765NHLBI NIH HHS R35 HL161195NHLBI NIH HHS R35HL161195
6 · The paper itself

Abstract

purposeArtificial intelligence (AI) has high diagnostic accuracy for coronary artery disease (CAD) from myocardial perfusion imaging (MPI). However, when trained using high-risk populations (such as patients with correlating invasive testing), the disease probability can be overestimated due to selection bias. We evaluated different strategies for training AI models to improve the calibration (accurate estimate of disease probability), using external testing.

methodsDeep learning was trained using 828 patients from 3 sites, with MPI and invasive angiography within 6 months. Perfusion was assessed using upright (U-TPD) and supine total perfusion deficit (S-TPD). AI training without data augmentation (model 1) was compared to training with augmentation (increased sampling) of patients without obstructive CAD (model 2), and patients without CAD and TPD < 2% (model 3). All models were tested in an external population of patients with invasive angiography within 6 months (n = 332) or low likelihood of CAD (n = 179).

resultsModel 3 achieved the best calibration (Brier score 0.104 vs 0.121, p < 0.01). Improvement in calibration was particularly evident in women (Brier score 0.084 vs 0.124, p < 0.01). In external testing (n = 511), the area under the receiver operating characteristic curve (AUC) was higher for model 3 (0.930), compared to U-TPD (AUC 0.897) and S-TPD (AUC 0.900, p < 0.01 for both).

conclusionTraining AI models with augmentation of low-risk patients can improve calibration of AI models developed to identify patients with CAD, allowing more accurate assignment of disease probability. This is particularly important in lower-risk populations and in women, where overestimation of disease probability could significantly influence down-stream patient management.

Indexed as

Coronary Artery DiseaseDeep LearningMyocardial Perfusion ImagingArtificial IntelligenceCoronary AngiographyFemaleHumansPerfusionSensitivity and SpecificityTomography, Emission-Computed, Single-PhotonCalibrationDeep learningDiagnostic accuracyModel trainingSex-specific analysis

Identifiers

PMID36194270
PMCPMC10042590

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.